Keith Klugman

Keith Klugman is director for pneumonia at the Bill & Melinda Gates Foundation, where he leads efforts to improve the development and delivery of pneumonia vaccines and expand the use of antibiotic treatments and diagnostic tools. An expert on antibiotic resistance in pneumonia pathogens and helped develop the pneumococcal vaccine, Klugman has long academic experience and has also worked for the World Health Organization and the U.S. Centers for Disease Control and Prevention.

Latest Articles

Could smartphones, thermal images or ultrasound save children from pneumonia?

about 10 years ago // World Pneumonia Day

How can innovative technology be used to save the lives of children at high risk of death from pneumonia? Keith Klugman, director of the Bill & Melinda Gates Foundation's pneumonia team, writes that new ways of approaching diagnostics and treatment are critical to preventing, detecting and treating pneumonia, in this guest commentary.

Every breath counts — help #FightPneumonia

about 11 years ago // #HealthyMeans Living Longer

Despite available interventions, pneumonia continues to be the leading infectious killer of kids under 5. A guest opinion on World Pneumonia Day by Keith Klugman, director for pneumonia at the Bill & Melinda Gates Foundation.

See all articles by Keith Klugman